explore -WSS

explore

author：comprehensive 2025-10-01 12:34:57 - browse：1

The sign of University of Texas MD Anderson Cancer Center in Houston, Texas in front of the Sheikh Zayed Building — coverage from STAT — Adobe

Early last year, MD Anderson Cancer Center leadership had a problem on their hands: a contentious dispute between one of its most powerful researchers and a junior scientist over authorship, credit, and charges of verbal abuse. High-ranking officials at the cancer center tried — and failed — to resolve the feud, and documents obtained by STAT shed new light on the deep divisions at the heart of this case.

The Texas cancer center outsourced assessing the conflict between early-career nephrologist Jamie Lin and leading oncologist Padmanee Sharma to the law firm Ropes & Gray. The firm investigated the authorship and scientific credit portions of the dispute and concluded that Sharma was likely responsible for a scientific hypothesis at the heart of the feud and should be named as a co-senior author on a key manuscript.

But a separate investigation, commissioned by Lin and conducted by a former official at the federal Office of Research Integrity, tells a somewhat different story. That review looked into plagiarism after Sharma claimed Lin had wrongly omitted the senior researcher as an author from a manuscript built on research to which Sharma contributed. But this second investigation found no evidence of plagiarism between two manuscripts submitted to the journals Cancer Immunology Research and Journal of Clinical Investigation Insight.

Lin provided STAT with copies of an executive summary of the Ropes & Gray investigation as well as the conclusions of the plagiarism investigation. These documents are alluded to in legal filings but have not been previously reported. Lin has filed a lawsuit against Sharma in the Harris County District Court alleging retaliation, harassment, threatening, and intellectual theft by Sharma; she’s also asking for $5 million in damages.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Duchenne breakthrough therapy leaves behind pioneering families
Next article： AI generated plenty of interest at JPM but not a lot of trust

focus

WSS

How Medicaid coverage policies for immigrants impact new moms

How digital therapeutics firms are pivoting after Pear's bankruptcy

Key House panel plots a new health care package

Gilead’s Trodelvy fails in lung cancer, raises questions on ADCs

How dance can help nurses traumatized by Covid

eGenesis tests gene

leisure time

explore

Wikipedia

In age of alternative facts, a scholarly course on calling out crap

Startup Neumora takes a novel depression drug to Phase 3

United colonoscopy coverage change 'may cost lives,' doctors say

WHO calls for emergency meeting on new China virus, as cases spread

Medical leaders decry Supreme Court decision on affirmative action

How Medicaid coverage policies for immigrants impact new moms

After affirmative action ruling, medical educators look to 'holistic review'

Francis Collins on trust in science and how Covid communications failed

Peter Hotez and the public health issue of online harassment

In early work, researchers turn to CRISPR to treat Alzheimer's

Wikipedia

Gilead’s Trodelvy fails in lung cancer, raises questions on ADCs

Why hospitals are withdrawing from US News rankings

Research misconduct: Proposed new rules face resistance

Prior authorization will have to move faster under new Biden rule

EU regulator recommends expanding Mounjaro approval to obesity

Sanders adds drug shortage policies to pandemic preparedness bill

hotspot

focus

leisure time

entertainment